Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries
2015
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
The Detection of Monkeypox in Humans in the Western Hemisphere
2004 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Anticoagulation and minor oral surgery: Should the anticoagulation regimen be altered?
2000
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
1989
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Multiple roles of CD90 in cancer
2016
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Evidence-Based Management of Anticoagulant Therapy
2012
PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
1991
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries
2005
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Travel and venous thrombosis: a systematic review
2007
Unresolved issues in anticoagulant therapy
2003
Comparison of ‘sequential’ versus ‘standard’ chemotherapy as re‐induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML‐R trial
2001
Porphyrias
2010 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
1998 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Targeting multidrug resistance in cancer
2006 Standout
The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
2001
Mouse and human dendritic cell subtypes
2002 Standout
Executive Summary
2012 Standout
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
1999 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells
2011
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
1998 Standout
Reporting outcomes in Hodgkin's disease and lymphoma.
1987
Dendritic cells: from ontogenetic orphans to myelomonocytic descendants
1996
Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe?
2009
Cancer of the Ovary
2004 Standout
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
1992 StandoutNobel
Prognostic value of S‐phase cells in AML patients
1995
Demystifying the development of dendritic cell subtypes, a little
2008
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro
2002 StandoutNobel
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
1996
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations.
1995
Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
2000 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The cutaneous porphyrias: a review
1999
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987
The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli
2000 StandoutNobel
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood
1990
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
The Risk of Determining Risk with Multivariable Models
1993 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Meta-analysis: Travel and Risk for Venous Thromboembolism
2009
Immunobiology of Dendritic Cells
2000 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
1997
Fourth universal definition of myocardial infarction (2018)
2018 Standout
The Hematopoietic Development of Dendritic Cells: A Distinct Pathway for Myeloid Differentiation
1996 StandoutNobel
Identification of proliferating dendritic cell precursors in mouse blood.
1992 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
BCL2 translocations in leukemias of mature B cells
1994
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome
2008
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of D Guyotat being referenced
Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries
1998
EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS
1996
t(2; 18) and t(18;22) Variant Chromosomal Translocations in B Cell Malignancies
1992
Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double‐blind randomized study
1997
Porphyria cutanea tarda after allogeneic bone marrow transplantation for chronic myelogenous leukemia
1990
Long term prognosis of patients with myocardial infarction and normal coronary angiography: impact of inherited coagulation disorders
2003
Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
1990
Expression of Thy-1 antigen (CDw90) on adult acute leukemia blast cells [letter]
1996
Culture of putative Langerhans cell bone marrow precursors: characterization of their phenotype.
1988
Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes.
2006
Successful pregnancy following allogeneic bone marrow transplantation after conditioning by thoraco-abdominal irradiation.
1991
Chromosome studies in stimulated lymphocytes of 50 patients with B-cell chronic lymphocytic leukemia.
1992
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemias.
1986
First-line rituximab (R) high-dose therapy (R-HDT) versus R-CHOP14 for young adults with diffuse large B-cell lymphoma: Preliminary results of the GOELAMS 075 prospective multicenter randomized trial.
2011
Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics.
1990
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
1986